Thread: Follow-up Study to Assess One Boost Immunization With AFFITOPEŽ PD01A With Regard to
View Single Post
Old 08-14-2014, 10:57 AM
Tupelo3 Tupelo3 is offline
Member
  
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default
Quote:
Originally Posted by badboy99 View Post
Follow-up Study to Assess One Boost Immunization With AFFITOPEŽ PD01A With Regard to Safety and Clinical Activity (AFF008A)

http://clinicaltrials.gov/ct2/show/N...&sel_rss=mod14

This is a follow-up study to assess safety and clinical activity of continued AFFITOPEŽ PD01A vaccinations in patients with Parkinson's disease. Patients, who have already participated in AFF008 will be involved and will be receive one boost immunization with AFFITOPEŽ PD01A. One study site in Vienna (Austria) will be involved.

In addition, up to 8 patients will be offered participation within an untreated control group.
Badboy, this is the follow-up AffiRis study that we've all be referring to over the past two weeks. It's not open for new recruits and, as you posted, the only test site is in Vienna.
Tupelo3 is offline   Reply With QuoteReply With Quote